A machine learning–based tool accurately predicted risk for recurrent inflammatory activity after DMT discontinuation in MS, highlighting its potential to guide personalized treatment decisions.

Almost half of women with MS remain untreated during family planning, though ocrelizumab is the most commonly used DMT in this population.

Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

The majority of infections in multiple sclerosis (MS) are reported in non-neurology practices, according to study results presented at the European Committee for Treatment and Research in Multiple ...

Patients with drug-resistant epilepsy who show no abnormalities on MRI are less likely to achieve seizure freedom following ...

A new federal vaccine panel appointed by US Health Secretary Robert F Kennedy Jr has recommended tighter restrictions on COVID-19 vaccines.

For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of ...

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.

Temperature sensitivity is associated with disease duration, dysautonomia, and quality of life in patients with multiple sclerosis.

Periodic limb movements occur frequently among persons with epilepsy but do not occur more often than among those with OSA.

A deep learning model based on mammographic features and age predicts cardiovascular risk with performance comparable to traditional risk equations.